Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Marcolongo

Showing results (101-110 of 290) with videos related to

Pageof 29
Sort By:
Minerva Medica|October 13, 1970
[Clinical research on the antipyretic effects of indomethacin in systemic hemopathies]R Marcolongo, G Bianco, N Di Paolo, et al.
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia|November 1, 1972
[Inhibitory action developed by tetanus toxin on serum and neural cholinesterases in various animals]G Leonardi, R Marcolongo, C Tiezzi, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Biochemical and morphological study of human articular chondrocytes cultivated in the presence of pulsed signal therapyA Fioravanti, F Nerucci, G Collodel, et al.
Clinical and Experimental Rheumatology|January 1, 1986
Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritisN Giordano, S Sancasciani, C Borghi, et al.
Journal of Biomolecular Structure & Dynamics|October 6, 2000
Density functional geometry optimization and energy calculations of calcium(II)-triphosphate complexes. Polyphosphates as possible dissolving agents for calcium pyrophosphate dihydrate crystals in chondrocalcinosis diseaseR Cini, D Chindamo, M Catenaccio, et al.
Journal of the American College of Cardiology|November 1, 1995
Immunosuppressive therapy prevents recurrent pericarditisR Marcolongo, R Russo, F Laveder, et al.
Minerva Medica|October 13, 1981
[Apical pulmonary fibrosis in the course of ankylosing spondyloarthritis]N Giordano, R Marcolongo, M Lucchese, et al.
Clinical Rheumatology|June 1, 1989
An immunomodulating drug, thymopentin, in the treatment of progressive systemic sclerosisN Giordano, G Biasi, A Taddeo, et al.
Recenti Progressi in Medicina|October 1, 1993
[Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus]C Francioni, A Fioravanti, R Gelli, et al.
Current Cardiology Reports|May 26, 2017
Myocarditis: A Clinical OverviewA L P Caforio, G Malipiero, R Marcolongo, et al.
Pageof 29

Showing results (101-110 of 290) with videos related to

Sort By:
Pageof 29
Minerva Medica|October 13, 1970
[Clinical research on the antipyretic effects of indomethacin in systemic hemopathies]R Marcolongo, G Bianco, N Di Paolo, et al.
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia|November 1, 1972
[Inhibitory action developed by tetanus toxin on serum and neural cholinesterases in various animals]G Leonardi, R Marcolongo, C Tiezzi, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Biochemical and morphological study of human articular chondrocytes cultivated in the presence of pulsed signal therapyA Fioravanti, F Nerucci, G Collodel, et al.
Clinical and Experimental Rheumatology|January 1, 1986
Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritisN Giordano, S Sancasciani, C Borghi, et al.
Journal of Biomolecular Structure & Dynamics|October 6, 2000
Density functional geometry optimization and energy calculations of calcium(II)-triphosphate complexes. Polyphosphates as possible dissolving agents for calcium pyrophosphate dihydrate crystals in chondrocalcinosis diseaseR Cini, D Chindamo, M Catenaccio, et al.
Journal of the American College of Cardiology|November 1, 1995
Immunosuppressive therapy prevents recurrent pericarditisR Marcolongo, R Russo, F Laveder, et al.
Minerva Medica|October 13, 1981
[Apical pulmonary fibrosis in the course of ankylosing spondyloarthritis]N Giordano, R Marcolongo, M Lucchese, et al.
Clinical Rheumatology|June 1, 1989
An immunomodulating drug, thymopentin, in the treatment of progressive systemic sclerosisN Giordano, G Biasi, A Taddeo, et al.
Recenti Progressi in Medicina|October 1, 1993
[Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus]C Francioni, A Fioravanti, R Gelli, et al.
Current Cardiology Reports|May 26, 2017
Myocarditis: A Clinical OverviewA L P Caforio, G Malipiero, R Marcolongo, et al.
Pageof 29